An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck sig

来源 :中国药理学报(英文版) | 被引量 : 0次 | 上传用户:liuya
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Rheumatoid arthritis(RA)is a chronic systemic autoimmune disease characterized by synovitis and the destruction of small joints.Emerging evidence shows that immunoglobulin D(IgD)stimulation induces T-cell activation,which may contribute to diseases pathogenesis in RA.In this study,we investigated the downstream signaling pathways by which IgD activated T cells as well as the possible role of IgD in the T-B interaction.Peripheral blood mononuclear cells were isolated from peripheral blood of healthy controls and RA patients.We demonstrated that IgD activated T cells through IgD receptor(IgDR)-lymphocyte-specific protein tyrosine kinase(Lck)-zeta-associated protein 70(ZAP70)/phosphatidylinositol 3-kinase(PI3K)/nuclear factor kappa-B(NF-κB)signaling pathways;IgD-induced CD4+T cells promoted the proliferation of CD19+B cells in RA patients.A novel fusion protein IgD-Fc-Ig(composed of human IgD-Fc domain and IgG1 Fc domain,which specifically blocked the IgD-IgDR binding)inhibited the coexpression of IgDR and phosphorylated Lck(p-Lck)and the expression levels of p-Lck,p-ZAP70,p-PI3K on CD4+T cells,and decreased NF-κB nuclear translocation in Jurkat cells.Meanwhile,IgD-Fc-Ig downregulated the expression levels of CD40L on CD4+T cells as well as CD40,CD86 on CD19+B cells in RA patients and healthy controls.It also decreased the expression levels of CD40L on CD4+T cells and CD40 on CD19+B cells from spleens of collagen-induced arthritis(CIA)mice and reduced IL-17A level in mouse serum.Moreover,administration of IgD-Fc-Ig(1.625-13 mg/kg,iv,twice a week for 4 weeks)in CIA mice dose-dependently decreased the protein expression levels of CD40,CD40L,and IgD in spleens.IgD-Fc-Ig restrains T-cell activation through inhibiting IgD-IgDR-Lck-ZAP70-PI3K-NF-KB signaling,thus inhibiting B-cell activation.Our data provide experimental evidences for application of IgD-Fc-Ig as a highly selective T cell-targeting treatment for RA.
其他文献
Ischemia/reperfusion(I/R)injury is a major cause of acute kidney injury(AKI)in clinic.The activation of NLRP3 inflammasome is associated with inflammation and renal injury in l/R-induced AKI.In the current study we explored the molecular and cellular mech
We are pleased to present a Special Column on“Drug-and Chemical-induced Liver Injury”.The scope of articles in this issue is diverse,covering a wide range of unanswered questions in this research area faced by both clinicians and basic researchers.Liver i
期刊
目的:建立盐酸氨溴索口服液中抑菌剂及矫味剂含量测定方法并考察全国范围内该品种抑菌剂和矫味剂添加情况.方法:采用资生堂MGII C18(250 mm×4.6 mm,5μm)色谱柱,以0.02 mol·L-1乙酸铵溶液(用冰醋酸调节pH至4.5)-甲醇为流动相,梯度洗脱,流速1.0 mL·min-1,柱温为30℃,DAD检测器,检测波长为254 nm和230 nm.结果:盐酸氨溴索与4种抑菌剂、3种矫味剂色谱峰均能良好分离,并质量浓度分别在0.005~0.15 mg· mL-1范围内,苯甲酸钠(r=1.000
High mobility group box 1(HMGB1)is a ubiquitous nuclear protein that is present in almost all cells and regulates the activity of innate immune responses in both intracellular and extracellular settings.Current evidence suggests that HMGB1 plays a pivotal
Previous reports suggested that cinnamaldehyde(CA),the bioactive ingredient in Cinnamomum cassia,can suppress tumor growth,migratory,and invasive abilities.However,the role and molecular mechanisms of CA in GC are not completely understood.In the present
Hepatocellular carcinoma(HCC),the most prevalent liver cancer,is considered one of the most lethal malignancies with a dismal outcome mainly due to frequent intrahepatic and distant metastasis.In the present study,we demonstrated that oroxylin A,a natural
The tumor suppressor p53 is usually inactivated by somatic mutations in malignant neoplasms,and its reactivation represents an attractive therapeutic strategy for cancers.Here,we reported that a new quinolone compound RYL-687 significantly inhibited non-s
White matter injury is the major pathological alteration of subcortical ischemic vascular dementia(SIVD)caused by chronic cerebral hypoperfusion.It is characterized by progressive demyelination,apoptosis of oligodendrocytes and microglial activation,which
As a member of the potassium calcium-activated channel subfamily,increasing evidence suggests that KCNN4 was associated with malignancies.However,the roles and regulatory mechanisms of KCNN4 in PDAC have been little explored.In this work,we demonstrated t
Urate transporter 1(URAT1)and glucose transporter 9(GLUT9)are important targets for the development of uric acid-lowering drugs.We previously showed that the flexible linkers of URAT1 inhibitors could enhance their potency.In this study we designed and sy